AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-6.53%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$97.4M
AUM Growth
–
Cap. Flow
+$97.4M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
184
New
184
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$12.8M |
| 2 |
Rithm Capital
RITM
|
$3.2M |
| 3 |
Mr. Cooper
COOP
|
$2.14M |
| 4 |
Sanofi
SNY
|
$2.11M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$2.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.93% |
| 2 | Real Estate | 12% |
| 3 | Financials | 8.32% |
| 4 | Technology | 3.61% |
| 5 | Industrials | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $12.8M | 13.1% |
+157,224
| New | +$12.8M |
|
|
2
Rithm Capital
RITM
$6.57B
| $3.2M | 3.28% |
+437,019
| New | +$3.2M |
|
|
3
Mr. Cooper
COOP
$12.1B
| $2.14M | 2.19% |
+52,740
| New | +$2.14M |
|
|
4
Sanofi
SNY
$121B
| $2.11M | 2.17% |
+55,500
| New | +$2.11M |
|
|
5
iShares Russell 1000 Value ETF
IWD
$63.5B
| $2.1M | 2.15% |
+15,402
| New | +$2.1M |
|
6
Invesco S&P 500 Pure Value ETF
RPV
$1.36B
| $2.08M | 2.14% |
+29,841
| New | +$2.08M |
|
7
Procept Biorobotics
PRCT
$2.23B
| $2.07M | 2.13% |
+50,000
| New | +$2.07M |
|
8
GSK
GSK
$79.9B
| $2.06M | 2.11% |
+70,000
| New | +$2.06M |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.88M | 1.93% |
+30,438
| New | +$1.88M |
|
|
WBA
10
DELISTED
Walgreens Boots Alliance
WBA
| $1.71M | 1.76% |
+54,500
| New | +$1.71M |
|
|
EFC
11
Ellington Financial
EFC
$1.36B
| $1.47M | 1.5% |
+128,879
| New | +$1.47M |
|
|
CYBE
12
DELISTED
Cyberoptics Corp
CYBE
| $1.35M | 1.38% |
+25,000
| New | +$1.35M |
|
13
PennyMac Financial
PFSI
$5.69B
| $1.34M | 1.37% |
+31,123
| New | +$1.34M |
|
14
Galapagos
GLPG
$2.07B
| $1.28M | 1.31% |
+30,000
| New | +$1.28M |
|
15
AeroVironment
AVAV
$12.1B
| $1.25M | 1.28% |
+15,000
| New | +$1.25M |
|
|
PETQ
16
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.24M | 1.27% |
+179,000
| New | +$1.24M |
|
17
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.2M | 1.23% |
+159,500
| New | +$1.2M |
|
18
Starwood Property Trust
STWD
$7.44B
| $1.18M | 1.22% |
+65,000
| New | +$1.18M |
|
19
Viatris
VTRS
$12.3B
| $1.18M | 1.22% |
+139,000
| New | +$1.18M |
|
20
Fulgent Genetics
FLGT
$679M
| $1.16M | 1.19% |
+30,500
| New | +$1.16M |
|
21
Collegium Pharmaceutical
COLL
$1.22B
| $1.1M | 1.13% |
+68,500
| New | +$1.1M |
|
22
Allient
ALNT
$769M
| $1.07M | 1.1% |
+37,500
| New | +$1.07M |
|
|
MFA
23
MFA Financial
MFA
$1.05B
| $1.04M | 1.06% |
+133,230
| New | +$1.04M |
|
24
Puma Biotechnology
PBYI
$254M
| $984K | 1.01% |
+415,000
| New | +$984K |
|
|
TSVT
25
DELISTED
2seventy bio
TSVT
| $975K | 1% |
+67,000
| New | +$975K |
|